Company Filing History:
Years Active: 2009
Title: Kevin K Barvian: Innovator in Pharmaceutical Chemistry
Introduction
Kevin K Barvian is a notable inventor based in Morrisville, NC (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on creating small molecule, guanidine-containing molecules that have the potential to treat various diseases.
Latest Patents
Barvian holds a patent for "Substituted quinazolinone compounds." This patent describes a variety of small molecules capable of acting as MC4-R agonists. These compounds are particularly useful in treating MC4-R mediated diseases when administered to subjects. The patent outlines the specific structures of the compounds, designated as IA, IB, and IC, with defined variables.
Career Highlights
Kevin K Barvian is currently employed at Novartis Vaccines & Diagnostics GmbH. His role involves extensive research and development in the pharmaceutical sector, where he applies his expertise to innovate and improve therapeutic options.
Collaborations
Throughout his career, Barvian has collaborated with esteemed colleagues, including Rustum S Boyce and Natalia Aurrecoechea. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Kevin K Barvian's contributions to pharmaceutical chemistry and his innovative patent work exemplify his commitment to advancing medical science. His ongoing efforts at Novartis Vaccines & Diagnostics GmbH continue to impact the field positively.